Back to Journals » Core Evidence » Volume 2 » Issue 3

Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease

Total article views   Abstract views HTML views PDF downloads Totals
6,751 Dovepress* 6,751 0+ 2,100 6,751
Totals 6,751 0 2,100 6,751
*Since 15 September 2007
+Since July 2016

View citations on Google Scholar